Articles

Videos

Podcasts

A patient with multiple providers and health problems seeks a pharmacist’s knowledge for managing her prescribed and OTC drug products.

Brown Bag Consult®: Breast Cancer and Additional Stressors

Avapritinib is approved for adult patients with advanced systemic mastocytosis, including individuals with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

Updated research offers an additional 2 years of follow-up data and statistics on treatment with a combination of ibrutinib and venetoclax in patients with chronic lymphocytic leukemia.

Study: Combination Targeted Therapy Provides Durable Remission for Patients with Chronic Lymphocytic Leukemia

Susan Lang, MA, MBA, the CEO of XIL Health and former senior executive with Express Grips, discusses what might happen to independent pharmacies if things continue as they are following the financial difficulties of the pandemic.

Expert: Financial Burdens on Small Chains, Independent Pharmacies Are Creating Pharmacy Deserts

There is ample evidence to suggest that there can be considerable variability in pharmacists’ tenacity to provide comprehensive care to patients. 

Tip of the Week: Pharmacists’ Attitudes and Beliefs Are Important

A lower antibody response found in one-fourth of patients taking methotrexate does not necessarily mean that these patients are not protected against COVID-19.

Study Suggests Some Patients Taking Anti-Inflammatory Drugs May Have Weaker Immune Response to COVID-19 Vaccines

Common factors that contributed to increased dissatisfaction at
work included workflow disruptions, role conflict, quantity of work,
organizational culture, and leadership support.

Survey: High Levels of Burnout are Prevalent Among Hematology/Oncology Pharmacists

The researchers found that the effect of fatigue from sleep disruption increased among patients with diabetes.

Sleep Issues Connected to Higher Risk of Death, Specifically for People with Diabetes

The addition of daratumumab to lenalidomide and dexamethasone resulted in a significant benefit to overall survival in patients with newly diagnosed multiple myeloma who were ineligible for autologous stem cell transplant and were treated to progression, according to the results of the phase 3 MAIA study.

All News